Landos Biopharma Plans To Effect 1-For-10 Reverse Stock Split
Portfolio Pulse from Benzinga Newsdesk
Landos Biopharma announced a 1-for-10 reverse stock split, effective May 26, 2023. The company's common stock will trade on a split-adjusted basis under the existing symbol 'LABP'.
May 25, 2023 | 8:11 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Landos Biopharma's 1-for-10 reverse stock split may lead to short-term price fluctuations as the market adjusts to the new share structure.
Reverse stock splits often lead to short-term price fluctuations as the market adjusts to the new share structure. However, the long-term impact on the stock price depends on the company's fundamentals and overall market conditions. In this case, the 1-for-10 reverse stock split may cause some short-term price fluctuations, but the long-term impact is uncertain.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100